You've just added:

Home / News

News + Media

August 08, 2022

Harrington Discovery Institute Scholar Moves New Drug into Clinical Trial

Richard Kramer, PhD, Hopes to Help Patients with Retinitis Pigmentosa Continue Reading

July 25, 2022

Nominations Open for 10th Annual International Harrington Prize for Innovation in Medicine

Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist Continue Reading

June 13, 2022

Harrington Discovery Institute Invites Proposals for 2023 Harrington UK Rare Disease Scholar Award

Grant programme seeks to advance novel therapies for rare diseases Continue Reading

April 28, 2022

Harrington Discovery Institute Announces 2022 Grant Funding to 11 Physician-Scientists

More than 150 drug discovery projects now supported by Harrington Discovery Institute Continue Reading

April 25, 2022

Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics

Epitopea, a transatlantic cancer Immunotherapeutics company, announces a $13.6M seed investment with support from Harrington Discovery Institute/University Health Holdings to create transformational immunotherapies that target broad cancer patients. Continue Reading

March 24, 2022

International Harrington Prize Jointly Awarded to Drs. James Crowe and Michel Nussenzweig

2022 Harrington Prize for Innovation in Medicine Recognizes Breakthrough Innovations in the Use of Human Antibodies to Treat COVID-19March 24, 2022, Cleveland, Ohio – The ninth annual Harrington Prize for Innovation in Medicine has been jointly awarded to James E. Crowe, Jr., MD, Director, Vanderbilt Vaccine Center and... Continue Reading

February 23, 2022

Harrington Discovery Institute Opens Call for 2023 Harrington Scholar-Innovator Award

February 23, 2022, CLEVELAND, Ohio USA - Harrington Discovery Institute at University Hospitals is now accepting the Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical... Continue Reading

December 09, 2021

LSU And Takeda Partner To Advance Harrington Scholar’s Therapy For Rare Neurological Disorders

New Orleans, LA – LSU Health New Orleans entered into an exclusive option and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) granting Takeda the exclusive right to develop further a technology invented at LSU Health New Orleans with the aim to discover potential therapeutics to treat rare... Continue Reading

October 18, 2021

Researchers Awarded $12 Million to Pursue Personalized Therapies for Severe Asthma

INDIANAPOLIS— A group of researchers led by Indiana University School of Medicine’s , has been awarded a research program project grant (P01) from the National Heart, Lung and Blood Institute. The award amounts to just over $12 million over the next five years and will fund the development of personalized therapeutic... Continue Reading